In the fourth and last year of the multi-annual work programme under our FPA 2018-2021, the Smoke Free Partnership coalition work plan for 2021 will continue the work towards the achievement of the overarching goal of preventing cancer and chronic diseases through smoking prevention at EU and national level with a special focus on young people and health in all policies:
- The campaign for increasing minimum excise duties on tobacco products as part of the revision of the EU Tobacco Tax Directive.
- The campaign to promote tobacco control research.
- The campaign to recognise the role of tobacco control funding within international development assistance programmes at EU and member state level as part of chronic disease prevention and sustainable health systems.
- The campaign to reduce and eliminate the tobacco industry interference in the fight against the illicit trade of tobacco products at EU and global level.
- The campaign to strengthen tobacco advertising, promotion and sponsorship (TAPS) restrictions and enforcement at national and European level.
- The campaign to communicate the role, value and impact of FCTC implementation to policy makers in EU and national institutions, particularly in the context of the lessons drawn from the coronavirus crisis for European health systems.
- The ongoing activities to monitor, expose and rebut tobacco industry interference across all policy work.
- Co-ordinating European civil society advocacy ahead of, during, and after the 9th Session of the Conference of the Parties to the FCTC (COP9) and the 2nd Meeting of the Parties to the Illicit Trade Protocol (MOP2) .


EPHA's 2021 SGA proposal includes the continuation of activities in eight thematic priorities, designed to conclude the multiannual 2018-2021 FPA and reach its objectives. This will provide ongoing support to all areas of the Third Health Programme despite its formal expiry at the end of 2020.

Crucially, EPHA proposes to broaden its activities in light of the new European Commission priorities announced in 2019, and the significant socio-economic challenges, policy and funding opportunities for public health resulting from the 2020 COVID-19 outbreak. Moreover, 2021 will be a year of transition for EPHA as a new Strategic Plan will be implemented that will contain flexible policy clusters. Therefore, the 2021 SGA proposal incorporates activities in relation to the pandemic recovery process, the EU Green Deal, increased digitalisation and other pressing issues.

A big focus will be placed on developing EPHA's "financing for health" thematic priority, which suffered from lower resources in previous years. Given the the unprecedented EU funding available to tackle health threats and ensure health systems strengthening, EPHA aims to play a key role in ensuring that available funding streams will be spent wisely, inter alia to boost prevention, avoid new health/social inequalities and avoid austerity policies in health.

EPHA’s annual work programme will provide added EU value by supporting policymakers and civil society through the development of policy recommendations, best practice exchanges and peer learning, linking up EU and national public health stakeholders and building capacity.

The work will be undertaken by EPHA’s Secretariat team, supported by interns, trainees and external consultants contributing to specific deliverables and milestones.



InfAct (Information for Action) is a JA on health information (HI). HI is essential to build up country specific and cross-country knowledge. HI is the basis to inform national health policies, to steer population health investment decisions, to assess the effectiveness of different approaches to enhance population health through promotion, prevention, treatments and care. Timely, up-to-date HI is also vital in framing EU wide programs and policies.

The major outcome expected of the JA is a sustainable solid infrastructure on EU HI through improving the availability of comparable, robust and policy-relevant health status data and health system performance information. Through country collaboration, the JA streamlines HI activities, reduces the data collection burden and works for a sustainable and robust data collection in Europe that facilitates and supports country knowledge, health research and policy making.

The JA gives attention to:

• develop the business case and roadmap for implementation of the European Research Infrastructure Consortium on Health Information for Research and Evidence-based Policy
o governance structures,
o national HI consortia and domain specific HI research networks
• assess HI systems (HIS) in MS and regions
• develop a roadmap for training in HI with the objective to tackle HI inequality through Europe
• standardize HI instruments, tools and methods
• strengthen the HI efficiency for public health policy through new ways of using health and non-health data sources
• enhance the introduction of the interoperability of health data sources
• enhance the translation of HI into public policy

The JA watches for the sustainability of all actions taken by the JA. Coordination, dialogue and interaction with the Commission Expert Groups on HI and on HSPA, Eurostat, DG Research and other relevant DGs, international organization (WHO, OECD) reinforce further the sustainability of the JAs’ work and outcomes.



The SHARP Joint Action will strengthen implementation of Decision 1082/2013/EU, supporting the EU level preparedness and responses to health threats and the implementation of the International Health Regulations (2005). The Joint Action implements actions mentioned in Annex 1 of the Annual Work plan 2018 of the EU Health Programme 2014-2020.
Through the Joint Action, the member and partner states and the Unions common ability to prevent, detect and respond to biological outbreaks, chemical contamination and environmental and unknown threats to human health will be strengthened. Special efforts will be employed to fill gaps that have been or will be identified in priority countries (countries that have biggest gaps in the capacity required for full IHR capability). The Joint action consists of 10 Work Packages, covering core public health capacities according to the IHR (2005). In addition to a coordination function, these will cover areas such as Communication, Evaluation, Sustainability, IHR core capacity, Preparedness, Laboratories, Training and exercises, Chemical threats and Clinical management.
SHARP will also collaborate with several other Joint Actions, specifically the “Healthy Gateways” that addresses Points of Entry, the Joint Action on Vaccination (EU-JAV) and the Joint Action on Antimicrobial Resistance (EU-JAMRAI).
The partnership of the joint action consists of 26 Associated Partners and 33 Affiliated Entities, which all will receive Commission co-funding. In addition there are 9 Collaborating Partners that will self-fund all activities that they participate in. Totally 30 countries (24 EU members, 3 EEA/EFTA members and 3 European neighborhood countries) participate in the Joint Action. The SHARP JA will liaise with and collaborate with the ECDC, the WHO EURO regional office and the WHO Health Emergency and IHR unit in Lyon, and IANPHI in relevant activities. Special emphasis will be made to avoid duplication of work for the member states.

